Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 147

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 147
---
     |                          |             |   |     |                          |             |   |     |                          |
| Common stock, $0.00001 par value; 100,000,000 shares authorized; 2,946,099 shares issued and outstanding at September 
 30, 2024, actual, 3,341,673 shares pro forma, and [*] shares pro forma as adjusted                                    |     |                          |          29 |   |     |                          |          33 |   |     |                          |
| Additional paid-in capital                                                                                            |     |                          |  31,664,226 |   |     |                          |  35,614,780 |   |     |                          |
| Accumulated deficit                                                                                                   |     |                          | (32,979,632 | ) |     |                          | (32,979,632 | ) |     |                          |
| Total stockholders’ equity (deficit)                                                                                  |     |                          |  (1,315,377 | ) |     |                          |   2,635,181 |   |     |                          |
| Total capitalization                                                                                                  |     | $                        |  (1,065,377 | ) |     |                          |   3,716,760 |   |     | $                        |

The number of shares of common stock issued and outstanding actual, pro forma and pro forma as adjusted in the table above excludes 1,231,910 shares reserved for issuance under our 2018 Equity Incentive Plan and 3,464,280 warrants which remain subject to exercise.

<div align='center'>DILUTION</div>

If you invest in our common stock in this offering, your ownership interest will be diluted immediately to the extent of the difference between the public offering price per share of our common stock and the as adjusted net tangible book value per share of our common stock immediately after this offering. As of September 30, 2024, our historical net tangible book value was $(1,315,377), or $(0.45) per share. Our historical net tangible book value is the amount of our total tangible assets less our total liabilities. Historical net tangible book value per share represents historical net tangible book value divided by the 2,946,099 shares of our common stock outstanding as of September 30, 2024.

After giving effect to our issuance and sale of common stock, or Pre-Funded Warrants on lieu thereof, in this offering at an assumed public offering price